subscribeSubscribe
Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin

Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin
PRESS RELEASE
08 Sep 2022
Share Share
Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe

Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe
EMA
17 Jun 2022
Share Share
Glenmark Pharma launches FDC drug for type 2 diabetes

Glenmark Pharma launches FDC drug for type 2 diabetes
PHARMABIZ
26 Oct 2021
Share Share
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin

Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
PRNEWSWIRE
29 Dec 2020
Share Share
Cipla acquires brand, trademark for anti-diabetic drug Vysov in India

Cipla acquires brand, trademark for anti-diabetic drug Vysov in India
BUSINESS-STANDARD
16 Dec 2019
Share Share
Cadila Healthcare gains 4% on launch of anti-diabetic tablet in India

Cadila Healthcare gains 4% on launch of anti-diabetic tablet in India
MONEYCONTROL
12 Dec 2019
Share Share
Panacea Biotec launches diabetes drug in India

Panacea Biotec launches diabetes drug in India
BIOSPECTRUMASIA
11 Dec 2019
Share Share
Panacea Biotec launches ViLACT brand in India to treat uncontrolled type 2 DM

Panacea Biotec launches ViLACT brand in India to treat uncontrolled type 2 DM
Panacea Biotec Limited PHARMABIZ
10 Dec 2019
Share Share
USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore

USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore
Teena Thacker ECONOMIC TIMES
10 Dec 2019
Share Share
Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn

Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn
BUSINESS STANDARD
04 Dec 2019
Share Share